PAGNI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 25.515
AS - Asia 19.652
EU - Europa 14.406
SA - Sud America 2.714
AF - Africa 491
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 14
Totale 62.842
Nazione #
US - Stati Uniti d'America 24.524
SG - Singapore 6.757
IT - Italia 4.336
VN - Vietnam 4.028
CN - Cina 3.787
HK - Hong Kong 2.273
RU - Federazione Russa 2.005
BR - Brasile 1.994
DE - Germania 1.801
SE - Svezia 1.399
IE - Irlanda 1.264
CA - Canada 717
GB - Regno Unito 666
FR - Francia 649
IN - India 547
UA - Ucraina 519
AT - Austria 369
FI - Finlandia 328
KR - Corea 312
BD - Bangladesh 309
ID - Indonesia 283
AR - Argentina 265
NL - Olanda 247
TR - Turchia 223
IQ - Iraq 191
MX - Messico 172
ES - Italia 169
ZA - Sudafrica 161
PL - Polonia 142
JP - Giappone 133
DK - Danimarca 122
PK - Pakistan 120
PH - Filippine 115
EC - Ecuador 100
SA - Arabia Saudita 100
VE - Venezuela 89
CH - Svizzera 87
CO - Colombia 86
UZ - Uzbekistan 68
BE - Belgio 58
MA - Marocco 55
PY - Paraguay 54
CL - Cile 53
EG - Egitto 46
MY - Malesia 46
JO - Giordania 45
LT - Lituania 44
TN - Tunisia 43
AU - Australia 41
KE - Kenya 39
ET - Etiopia 37
UY - Uruguay 32
AE - Emirati Arabi Uniti 31
GR - Grecia 28
TH - Thailandia 28
NP - Nepal 26
PE - Perù 26
DZ - Algeria 25
KZ - Kazakistan 25
AZ - Azerbaigian 23
OM - Oman 23
PT - Portogallo 22
AL - Albania 21
CR - Costa Rica 21
DO - Repubblica Dominicana 21
IR - Iran 21
LB - Libano 20
RO - Romania 20
IL - Israele 18
PS - Palestinian Territory 18
TW - Taiwan 17
CZ - Repubblica Ceca 16
NG - Nigeria 14
BO - Bolivia 13
JM - Giamaica 13
BG - Bulgaria 12
RS - Serbia 12
SN - Senegal 12
BY - Bielorussia 11
KG - Kirghizistan 11
PA - Panama 11
AM - Armenia 10
SY - Repubblica araba siriana 10
EU - Europa 9
MU - Mauritius 9
TT - Trinidad e Tobago 9
AO - Angola 8
HU - Ungheria 8
LV - Lettonia 8
SK - Slovacchia (Repubblica Slovacca) 8
NI - Nicaragua 7
NO - Norvegia 7
SC - Seychelles 7
GA - Gabon 6
HR - Croazia 6
MN - Mongolia 6
NZ - Nuova Zelanda 6
KW - Kuwait 5
PR - Porto Rico 5
SI - Slovenia 5
Totale 62.748
Città #
Singapore 3.808
Ann Arbor 3.559
Ashburn 2.430
Hong Kong 2.210
San Jose 2.037
Milan 1.332
Ho Chi Minh City 1.238
Fairfield 1.235
Dublin 1.227
Frankfurt am Main 1.122
Chandler 1.074
Woodbridge 1.034
Hanoi 959
Wilmington 803
Houston 794
New York 740
Santa Clara 632
Los Angeles 621
Dallas 615
Hefei 610
Beijing 537
Seattle 513
Dearborn 487
Chicago 458
Jacksonville 455
Cambridge 407
The Dalles 398
Toronto 391
Princeton 363
Seoul 287
Vienna 287
Lauterbourg 269
Shanghai 229
Buffalo 223
São Paulo 216
Nanjing 209
Council Bluffs 195
Jakarta 187
Moscow 176
Rome 154
Da Nang 147
Helsinki 142
Munich 139
Lawrence 136
Altamura 134
London 133
Dong Ket 124
Orem 118
Haiphong 111
Warsaw 105
Guangzhou 98
Nuremberg 93
Chennai 86
Denver 86
Kent 86
Tokyo 86
Montreal 83
San Diego 83
Hải Dương 81
Ha Long 80
Lissone 79
Nanchang 77
Boardman 76
Johannesburg 75
Baghdad 73
Ottawa 70
Lachine 69
Biên Hòa 66
Phoenix 66
Atlanta 65
Rio de Janeiro 65
Tashkent 64
Turin 63
Zurich 62
Salt Lake City 61
Brooklyn 59
Florence 58
Shenyang 58
Thái Nguyên 58
Lappeenranta 57
Stockholm 56
Naples 55
Mexico City 54
Monza 54
Quận Bình Thạnh 54
Brussels 52
Changsha 52
Hebei 52
Poplar 52
Istanbul 51
Amsterdam 50
Bắc Ninh 50
Can Tho 50
Dhaka 50
Falls Church 50
Tianjin 50
Turku 50
New Delhi 48
Manchester 47
Ninh Bình 47
Totale 39.017
Nome #
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 726
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 581
'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: Morphological criteria and clinical impact 531
Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI 461
The putative role of MALDI-MSI in the study of Membranous Nephropathy 421
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 416
Clinical-pathological issues in thyroid pathology: study on the routine application of NIFTP diagnostic criteria 415
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 403
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 400
The proteomic landscape of renal tumors 392
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 391
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 389
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 387
MALDI imaging in Fabry nephropathy: a multicenter study 387
Use of Shear Wave Elastography in the Sonographic Triage of Thyroid Nodules: Feasibility Study in a Series of Lesions Already Selected for Fine Needle Aspiration 384
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 377
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells 376
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 376
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 372
MiralysTM Ambergen. Sequential MALDI-HiPLEX-IHC and untargeted protein imaging to map the tumour-immune environment: academic researcher experience 371
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 371
Kidney Involvement 368
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 366
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 364
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 363
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 363
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 362
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 355
Proteomics for the diagnosis of thyroid lesions: Preliminary report 354
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 351
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 346
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 345
Proteomics for the study of new biomarkers in Fabry disease: State of the art 340
Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study 338
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 337
Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers 335
Virtual Guidance of Percutaneous Transthoracic Needle Biopsy with C-Arm Cone-Beam CT: Diagnostic Accuracy, Risk Factors and Effective Radiation Dose 335
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 330
PD-L1 Testing and Squamous Cell Carcinoma of the Head and Neck: A Multicenter Study on the Diagnostic Reproducibility of Different Protocols 330
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 330
"Pathologists in Venice - Real World Cases for an Immersive Training Experience": Education, Gaming, and Show 325
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 321
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 320
Estimating Fatty Pancreas: A Preoperative Bedside Assessment by Bioelectric Impedance Analysis: Implications for Pancreatic Surgery 312
Proteome analysis in thyroid pathology 309
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 309
Diagnostic performances of the acr-tirads system in thyroid nodules triage: A prospective single center study 307
Digital counting of tissue cells for molecular analysis: the QuANTUM pipeline 302
The first recorded use of microscopy in medicine: Pope Innocent XII's autopsy report 302
Nasopharyngeal Tonsils (Adenoids) Contain Extrathymic Corticothymocytes 300
Intermittent granulocyte maturation arrest, hypocellular bone marrow, and episodic normal neutrophil count can be associated with SRP54 mutations causing Shwachman–Diamond-like syndrome 299
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 297
Benchmarking digital displays (monitors) for histological diagnoses: the nephropathology use case 296
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 296
Unsupervised neural networks as a support tool for pathology diagnosis in MALDI-MSI experiments: A case study on thyroid biopsies 294
Use of diagnostic criteria from acr and eu-tirads systems to improve the performance of cytology in thyroid nodule triage 291
Machine learning streamlines the morphometric characterization and multi-class segmentation of nuclei in different follicular thyroid lesions: everything in a NUTSHELL 288
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 288
Thyroid disorders following hematopoietic stem cell transplantation in childhood: the impact of the conditioning regimen on thyroid dysfunction, volume changes and occurrence of nodules 288
C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool 284
The impact of the non-invasive follicular thyroid neoplasm with papillary-like nuclear feature terminology in the routine diagnosis of thyroid tumours 283
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 282
Monocyte–macrophage polarization and recruitment pathways in the tumour microenvironment of B-cell acute lymphoblastic leukaemia 280
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 279
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 279
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 279
Durán Madonna (c. 1435–1438) by Rogier van der Weyden: a case of congenital goiter 275
Thyroid function disorders and secondary cancer following haematopoietic stem cell transplantation in pediatrics: State of the art and practical recommendations for a risk-based follow-up 273
The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience 272
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 269
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 266
Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: Another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma 266
Thyrospheres from B-CPAP Cell Line with BRAF and TERT promoter mutations have Different Functional and Molecular Features than Parental Cells 265
MALDI-MSI analysis of cytological smears: The study of thyroid cancer 262
Upregulated microRNAs in membranous glomerulonephropathy are associated with significant downregulation of IL6 and MYC mRNAs 262
Exuberant plasmocytosis in bronchoalveolar lavage of the first patient requiring Extracorporeal Membrane Oxygenation for SARS-CoV-2 in Europe 258
Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV 257
Malignant epidermoid cyst of the pineal region with lumbar metastasis 255
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 254
PENTRAXIN 3 PLASMA LEVELS AT GRAFT-VERSUS-HOST DISEASE ONSET PREDICT DISEASE SEVERITY AND RESPONSE TO THERAPY IN CHILDREN GIVEN HEMATOPOIETIC STEM CELL TRANSPLANTATION 252
Improvements in digital pathology equipment for renal biopsies: updating the standard model 251
Immunosuppression in idiopathic membranous nephropathy: A double-edge sword 250
The UBC9/SUMO pathway affects E-cadherin cleavage in HPV-positive head and neck cancer 248
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 248
Solid cell nests of the thyroid gland: Morphological, immunohistochemical and genetic features 247
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 247
Combined transcranial and endoscopic nasal resection for esthesioneuroblastoma. Technical note 246
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 246
Thyreoglossal Duct Cyst with Evidence of Solid Cell Nests and Atypical Thyroid Follicles 242
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 241
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 241
The role of fine needle aspiration of orbital lesions: A case series 239
Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review 238
The therapeutic potential of an allosteric non-competitive CXCR1/2 antagonist for diabetic nephropathy 237
MALDI-MS imaging in the study of glomerulonephritis 233
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 231
Digital transition in pathology lab: a survey from the Lombardy region 231
Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma 231
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 231
Primary angiitis of the central nervous system: 2 atypical cases 229
Totale 31.742
Categoria #
all - tutte 198.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 198.655


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021709 0 0 0 0 0 0 0 0 0 0 271 438
2021/20222.765 265 367 305 217 129 208 94 117 126 246 221 470
2022/20234.783 500 1.309 433 416 274 730 75 326 384 78 168 90
2023/20244.436 156 178 186 222 475 1.014 852 134 420 150 161 488
2024/202511.484 526 1.039 852 547 925 460 575 401 1.211 1.730 1.251 1.967
2025/202627.778 4.279 2.435 2.285 3.190 3.131 1.438 4.288 1.308 2.197 2.428 799 0
Totale 64.362